WO2000075305A3 - Genes de candida albicans et les proteines codees par ces genes - Google Patents

Genes de candida albicans et les proteines codees par ces genes Download PDF

Info

Publication number
WO2000075305A3
WO2000075305A3 PCT/FR2000/001567 FR0001567W WO0075305A3 WO 2000075305 A3 WO2000075305 A3 WO 2000075305A3 FR 0001567 W FR0001567 W FR 0001567W WO 0075305 A3 WO0075305 A3 WO 0075305A3
Authority
WO
WIPO (PCT)
Prior art keywords
genes
proteins
candida albicans
polypeptides
proteins coded
Prior art date
Application number
PCT/FR2000/001567
Other languages
English (en)
Other versions
WO2000075305A2 (fr
Inventor
Jean-Louis Lalanne
Corinne Rocher
Original Assignee
Aventis Pharma Sa
Lalanne Jean Louis
Corinne Rocher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa, Lalanne Jean Louis, Corinne Rocher filed Critical Aventis Pharma Sa
Priority to AU55390/00A priority Critical patent/AU775543B2/en
Priority to EP00940455A priority patent/EP1190048A2/fr
Priority to JP2001502570A priority patent/JP2003501084A/ja
Publication of WO2000075305A2 publication Critical patent/WO2000075305A2/fr
Publication of WO2000075305A3 publication Critical patent/WO2000075305A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne les protéines de Candida albicans nommées ci-après PCaDR472, PCaDR489, 1PCaDR527, 2PCaDR527, PCaFL024, PCaNL260, PCaDR361 et leurs analogues ainsi que les polynucléotides (ARN, ADN) codant pour ces protéines ou pour les polypeptides analogues de ces protéines, le procédé de préparation de ces polypeptides et polynucléotides, leur utilisation pour la préparation d'inhibiteurs de ces protéines pouvant être utilisés comme agents antifongiques et les compositions pharmaceutiques contenant de tels inhibiteurs.
PCT/FR2000/001567 1999-06-09 2000-06-08 Genes de candida albicans et les proteines codees par ces genes WO2000075305A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU55390/00A AU775543B2 (en) 1999-06-09 2000-06-08 Novel candida albicans genes and proteins coded by said genes
EP00940455A EP1190048A2 (fr) 1999-06-09 2000-06-08 Genes de candida albicans et les proteines codees par ces genes
JP2001502570A JP2003501084A (ja) 1999-06-09 2000-06-08 新規なカンジダ・アルビカンス遺伝子及びこれらの遺伝子によりコードされるタンパク質

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR99/07250 1999-06-09
FR9907250A FR2794773B1 (fr) 1999-06-09 1999-06-09 Nouveaux genes de candida albicans et les proteines codees par ces genes

Publications (2)

Publication Number Publication Date
WO2000075305A2 WO2000075305A2 (fr) 2000-12-14
WO2000075305A3 true WO2000075305A3 (fr) 2001-06-28

Family

ID=9546547

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2000/001567 WO2000075305A2 (fr) 1999-06-09 2000-06-08 Genes de candida albicans et les proteines codees par ces genes

Country Status (5)

Country Link
EP (1) EP1190048A2 (fr)
JP (1) JP2003501084A (fr)
AU (1) AU775543B2 (fr)
FR (1) FR2794773B1 (fr)
WO (1) WO2000075305A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1212459A2 (fr) 1999-08-25 2002-06-12 Clarity Biosciences, Inc. Identification d'organismes par detection d'acide nucleique intronique ou de proteines codees
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
DE10142743B4 (de) * 2001-08-24 2006-01-26 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Biochips mit Dimorphismus-spezifischen Faktoren aus Candida albicans
CN113508176A (zh) * 2019-02-28 2021-10-15 米尼翁大学 用于控制白色念珠菌感染的反义寡聚物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALFONSO MENDOZA ET AL.: "Translation elongation factor 2 is encoded by a single essential gene in Candida albicans", GENE, vol. 229, no. 1-2, 18 March 1999 (1999-03-18), AMSTERDAM NL, pages 183 - 191, XP004161173 *

Also Published As

Publication number Publication date
AU775543B2 (en) 2004-08-05
EP1190048A2 (fr) 2002-03-27
FR2794773B1 (fr) 2001-07-27
AU5539000A (en) 2000-12-28
FR2794773A1 (fr) 2000-12-15
WO2000075305A2 (fr) 2000-12-14
JP2003501084A (ja) 2003-01-14

Similar Documents

Publication Publication Date Title
WO1996034107A3 (fr) Proteines antivirales, sequences d'adn codant pour ces proteines et utilisations
PL399351A1 (pl) Czasteczka przeciwciala, zwiazek ja zawierajacy, sekwencja DNA, wektor do klonowania lub ekspresji, komórka gospodarza, sposób wytwarzania czasteczki przeciwciala, kompozycja terapeutyczna lub diagnostyczna, zastosowanie czasteczki lub zwiazku
WO2002006316A3 (fr) Composes en rapport avec $g(a)-msh et methodes d'utilisation
YU19903A (sh) Novi receptor nukleinskih kiselina i polipeptida
WO2005113592A3 (fr) Polypeptides et conjugues interferon-alpha
SG143252A1 (en) Polymer derivatives
ZA200500716B (en) Solid pharmaceutical composition containing a lipophilic active principle and preparation method thereof
WO2002092818A3 (fr) Sequence du genome streptococcus agalactiae et ses utilisations
WO1999053040A3 (fr) Sequences d'acide nucleique humain provenant de tissu de tumeur ovarienne
WO2003025154A3 (fr) Procedes et compositions pour la construction et l'utilisation de genotheques de fusion
WO2002014485A3 (fr) Nouveau gene kallikreine
HUP0203957A2 (hu) Az érképződést és az érrendszeri permeabilitást módosító és gátló hatóanyagok
WO2004007664A3 (fr) Vecteurs d'acides nucleiques
PT1137413E (pt) Antagonistas nao-peptidicos do receptor de glp-1 e metodos de utilizacao
WO2000075305A3 (fr) Genes de candida albicans et les proteines codees par ces genes
WO2002086074A3 (fr) Compositions permettant la delivrance de composes dans des cellules et procedes d'utilisation
WO2003022868A3 (fr) Proteines pouvant se lier avec des metaux et procedes associes
WO2001071007A3 (fr) Polymorphisme genetique de la proteine et son utilisation
WO2002018576A3 (fr) Compositions et methodes associees aux genes specifiques du poumon
WO2001057069A3 (fr) Peptides capables de ciblage
WO2002007514A3 (fr) Vegf-b glycosylees et methode d'augmentation de la quantite de vegf-b solubles
WO2001058477A3 (fr) Immunisation d'un individu contre des carcinomes et leurs stades prealables
AR013801A1 (es) Nuevas moleculas de acido nucleico aislada, una proteina de epoxido hidrolasa de artropodo hematofago aislada, una formulacion de proteinas deepoxido hidrolasa de pulga, una composicion terapeutica que reduce la infestacion de ectoparasitos hematofagos; uso de dicha composicion para la
EP0950711A3 (fr) Récepteurs de Gonadotropine
WO2001092468A3 (fr) Nouvelles compositions pour l'expression du transporteur 1 d'histidine de peptide humain et leurs procedes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

WWE Wipo information: entry into national phase

Ref document number: 2000940455

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 502570

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 55390/00

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2000940455

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 55390/00

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 2000940455

Country of ref document: EP